Published Articles that Examine, Use, or Discuss the OAB-q

Acquadro C, Kopp Z, Coyne KS, et al. Translating overactive bladder questionnaires in 14 languages. Urology. Mar 2006;67(3):536-540.

Capo JP, Jr., Laramee C, Lucente V, Fakhoury A, Forero-Schwanhaeuser S. Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial. Int J Clin Pract. Jan 2008;62(1):39-46.

Coyne KS, Elinoff V, Gordon DA, et al. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. Int J Clin Pract. Jun 2008a;62(6):925-931.

Coyne KS, Margolis MK, Thompson C, Kopp Z. Psychometric Equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish. Value Health. May 16 2008b.

Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. Jun 2008c;101(11):1388-1395.

Coyne KS, Matza LS, Thompson C, Jumadilova Z, Bavendam T. The responsiveness of the OAB-q among OAB patient subgroups. Neurourol Urodyn. 2007;26(2):196-203.

Coyne KS, Matza LS, Thompson CL, Kopp ZS, Khullar V. Determining the importance of change in the overactive bladder questionnaire. J Urol. Aug 2006;176(2):627-632; discussion 632.

Coyne KS, Matza LS, Thompson CL. The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res. Apr 2005;14(3):849-855.

Coyne KS, Payne C, Bhattacharyya SK, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health. Jul-Aug 2004;7(4):455-463.

Coyne KS, Zhou Z, Bhattacharyya SK, et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. Dec 2003a;92(9):948-954.

Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int. Nov 2003b;92(7):731-735.

Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. Sep 2002;11(6):563-574.

Garely AD, Lucente V, Vapnek J, Smith N. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Ann Pharmacother. Mar 2007;41(3):391-398.

Herschorn S, Heesakkers J, Castro-Diaz D, et al. Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*. Curr Med Res Opin. Dec 2008;24(12):3513-3521.

Matza LS, Brewster-Jordan J, Zyczynski TM, Bavendam T. An updated review of quality-of-life questionnaires for urinary incontinence and overactive bladder: Which ones to use and why. Current Bladder Dysfunction Reports. 2006;1:71-80.

Matza LS, Thompson CL, Krasnow J, et al. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn. 2005;24(3):215-225.

Yang Y, Brazier J, Tsuchiya A, Coyne K. Estimating a Preference-Based Single Index from the Overactive Bladder Questionnaire. Value Health. Jul 18 2008.

Conference Presentations

ISOQOL 2006: OAB-5D

Brazier JE, Tsuchiya A, Yang Y, Young TA, & Coyne K. Estimating a preference-based single index from the Overactive Bladder Questionnaire. Poster presented at the 13th Annual Conference of the International Society for Quality of Life Research; October 10-14, 2006; Lisbon, Portugal. Click here for a PDF of the poster.

ICS 2004: Short Form

Coyne KS, Lai JS, Zyczynski T, Kopp Z, Avery K, & Abrams P. An overactive bladder symptom and quality-of-life short form: development of the Overactive Bladder Questionnaire (OAB-q) short form (SF). Presented at the Joint Meeting of the International Continence Society and the International Urogynecological Association; August 23-27, 2004; Paris, France. Click here for a PDF of the presentation.

ICS 2004: Awareness Tool

Coyne KS, Margolis MK, Zyczynski T, Elinoff V, & Roberts R. Validation of an OAB screener in a primary care patient population in the US. Presented at the Joint Meeting of the International Continence Society and the International Urogynecological Association; August 23-27, 2004; Paris, France. Click here for a PDF of the presentation.

Selected References for the N-QOL

Published Article

Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, MacDonagh RP, & Noble JG. Development and validation of a quality-of-life measure for men with Nocturia. Urology 2004;63:481-486.

Conference Presentation

ICS 2003: Nocturia

Coyne KS & Zhou S. Nocturia has a significant impact on health related quality of life. Oral poster presentation at International Continence Society, October, 2003. Click here for a PDF of the presentation.

Selected References for the PPBC

Published Articles

Herschorn S, Heesakkers J, Castro-Diaz D, Wang JT, Brodsky M, Guan Z. Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms. Curr Med Res Opin. 2008;24(12):3513-3521.

Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006;49(6):1079-1086.

Selected Reference for the BSW

Pleil AM, Coyne KS, Reese PR, et al. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005;8 Suppl 1:S25-34.